Globus strengthens position as UK's leading force in hand protection

Published: 5-Mar-2010
Personal Protection Regulatory

Progressing after 15 years in partnership with Showa Glove Company, UK leader in advanced hand protection solutions, Globus (Shetland) Ltd has announced an exciting addition to its market-leading portfolio.

Progressing after 15 years in partnership with Showa Glove Company, UK leader in advanced hand protection solutions, Globus (Shetland) Ltd has announced an exciting addition to its market-leading portfolio.

From 1 March 2010 Globus has taken over all Showabest activities in the UK and Ireland. The addition of unique chemical protection products and the world's most advanced disposable glove offer gives Globus the only product portfolio that can claim the original iconic styles that created totally new markets for their distribution partners.

Grip style gloves, Palm Fit technology, Dyneema cut protective gloves and the world's first and patented disposable nitrile glove were all created by the Showabest organisation.

Innovative sales & marketing techniques have seen Globus rise to the forefront of the hand protection sector. Its customers now look set to enjoy the benefits of an invigorated range supported by UK stock and extensive sales support infrastructure.
See more

You may also like

Regulatory

Poolbeg Pharma granted European patent for flu drug

Read more
POLB 001 targets the body's inflammation machinery and prevents dangerous immune overreactions. The drug could also be used in the treatment of other inflammation-based diseases, such as Cytokine Release Syndrome

Trending Articles

  1. UK pharma shifts as Merck and AstraZeneca scale back: can CDMOs fill the gap? Recent major site withdrawals and investment pauses have raised concerns about the UK’s industrial strength. But CDMOs say agility, innovation and technical expertise could redefine how and where drugs are made
  2. TrakCel launches CGT Gateway to streamline cell and gene therapy access for healthcare providers The gateway will be a single sign-on platform designed to reduce portal fatigue and simplify how healthcare professionals manage cell and gene therapy products, supporting smoother coordination across clinics, networks and stakeholders
  3. Nanoform granted European Commercial cGMP Manufacturing Licence for APIs The Finnish company is now authorised to manufacture nanoformed APIs for the European market and for countries in the Middle East and North Africa, Asia and the Americas, where mutual recognition applies to the European license
  4. Grifols secures first EU approval for fibrinogen concentrate Prufibry in Germany Germany has granted the first marketing authorisation for Grifols’ fibrinogen concentrate Prufibry, approved for treating congenital and acquired fibrinogen deficiency
  5. IMed Group appoints Parminder Kalle as Chief Commercial Officer Parminder Kalle to lead IMed’s new chapter of international growth

You may also like

Regulatory

Poolbeg Pharma granted European patent for flu drug

POLB 001 targets the body's inflammation machinery and prevents dangerous immune overreactions. The drug could also be used in the treatment of other inflammation-based diseases, such as Cytokine Release Syndrome
Regulatory

BCMPA warns Chancellor: avoid new tax burdens on SMEs in upcoming Budget

The BCMPA is urging the UK Government to ease pressure on small manufacturers by reducing National Insurance costs, cutting red tape and considering SME impact assessments, warning that rising costs and uncertainty are stalling investment and growth
Regulatory

HHS removes long-standing FDA menopause HRT warnings in landmark move for women’s health in the US

The US Department of Health and Human Services has announced the removal of broad FDA boxed warnings from menopause hormone replacement therapy, following a full scientific review
Manufacturing

Breaking down silos and building in seamless scale

A Q&A with Kindeva's Tommy Schornak on the Bridgeton facility, Annex 1 compliance and scaling sterile injectable production
Regulatory

TrakCel launches CGT Gateway to streamline cell and gene therapy access for healthcare providers

The gateway will be a single sign-on platform designed to reduce portal fatigue and simplify how healthcare professionals manage cell and gene therapy products, supporting smoother coordination across clinics, networks and stakeholders
Regulatory

Grifols secures first EU approval for fibrinogen concentrate Prufibry in Germany

Germany has granted the first marketing authorisation for Grifols’ fibrinogen concentrate Prufibry, approved for treating congenital and acquired fibrinogen deficiency
Regulatory

BetaGlue Therapeutics gains MHRA approval for pancreatic cancer trial

YntraDose, the innovative radiotherapy treatment for unresectable locally advanced pancreatic cancer, has been granted an early feasibility clinical investigation and will assess safety and performance in patients
Subscribe now